The global Parkinson Disease Drug market size was valued at USD 5651 million in 2022 and is forecast to a readjusted size of USD 8439.2 million by 2029 with a CAGR of 5.9% during review period.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
This report is a detailed and comprehensive analysis for global Parkinson Disease Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Parkinson Disease Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Parkinson Disease Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Parkinson Disease Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Parkinson Disease Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parkinson Disease Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parkinson Disease Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Parkinson Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson Disease Drug, with revenue, gross margin and global market share of Parkinson Disease Drug from 2018 to 2023.
Chapter 3, the Parkinson Disease Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Parkinson Disease Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson Disease Drug.
Chapter 13, to describe Parkinson Disease Drug research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Parkinson Disease Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson Disease Drug by Type
1.3.1 Overview: Global Parkinson Disease Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Parkinson Disease Drug Consumption Value Market Share by Type in 2022
1.3.3 Sinemet-CR
1.3.4 Trastal
1.3.5 Madopar
1.3.6 COMT Inhibitor
1.3.7 Other
1.4 Global Parkinson Disease Drug Market by Application
1.4.1 Overview: Global Parkinson Disease Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Under 40 Years Old
1.4.3 40-65 Years Old
1.4.4 Above 65 Years Old
1.5 Global Parkinson Disease Drug Market Size & Forecast
1.6 Global Parkinson Disease Drug Market Size and Forecast by Region
1.6.1 Global Parkinson Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Parkinson Disease Drug Market Size by Region, (2018-2029)
1.6.3 North America Parkinson Disease Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Parkinson Disease Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Parkinson Disease Drug Market Size and Prospect (2018-2029)
1.6.6 South America Parkinson Disease Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Parkinson Disease Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Parkinson Disease Drug Product and Solutions
2.1.4 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments and Future Plans
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Parkinson Disease Drug Product and Solutions
2.2.4 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Akorn Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinson Disease Drug Product and Solutions
2.3.4 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Parkinson Disease Drug Product and Solutions
2.4.4 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
2.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson Disease Drug Product and Solutions
2.7.4 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Kyowa Hakko Kirin Pharma
2.8.1 Kyowa Hakko Kirin Pharma Details
2.8.2 Kyowa Hakko Kirin Pharma Major Business
2.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
2.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business
2.9.3 Astellas Pharma Parkinson Disease Drug Product and Solutions
2.9.4 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Astellas Pharma Recent Developments and Future Plans
2.10 Desitin Arzneimittel
2.10.1 Desitin Arzneimittel Details
2.10.2 Desitin Arzneimittel Major Business
2.10.3 Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
2.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Desitin Arzneimittel Recent Developments and Future Plans
2.11 Endo Pharmaceuticals
2.11.1 Endo Pharmaceuticals Details
2.11.2 Endo Pharmaceuticals Major Business
2.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
2.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.12 F.Hoffmann-La Roche
2.12.1 F.Hoffmann-La Roche Details
2.12.2 F.Hoffmann-La Roche Major Business
2.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
2.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 F.Hoffmann-La Roche Recent Developments and Future Plans
2.13 H.Lundbeck
2.13.1 H.Lundbeck Details
2.13.2 H.Lundbeck Major Business
2.13.3 H.Lundbeck Parkinson Disease Drug Product and Solutions
2.13.4 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 H.Lundbeck Recent Developments and Future Plans
2.14 Valeant
2.14.1 Valeant Details
2.14.2 Valeant Major Business
2.14.3 Valeant Parkinson Disease Drug Product and Solutions
2.14.4 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Valeant Recent Developments and Future Plans
2.15 Apokyn
2.15.1 Apokyn Details
2.15.2 Apokyn Major Business
2.15.3 Apokyn Parkinson Disease Drug Product and Solutions
2.15.4 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Apokyn Recent Developments and Future Plans
2.16 Orion
2.16.1 Orion Details
2.16.2 Orion Major Business
2.16.3 Orion Parkinson Disease Drug Product and Solutions
2.16.4 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Orion Recent Developments and Future Plans
2.17 Stada Arzneimittel
2.17.1 Stada Arzneimittel Details
2.17.2 Stada Arzneimittel Major Business
2.17.3 Stada Arzneimittel Parkinson Disease Drug Product and Solutions
2.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Stada Arzneimittel Recent Developments and Future Plans
2.18 US WorldMeds
2.18.1 US WorldMeds Details
2.18.2 US WorldMeds Major Business
2.18.3 US WorldMeds Parkinson Disease Drug Product and Solutions
2.18.4 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 US WorldMeds Recent Developments and Future Plans
2.19 Bausch Health
2.19.1 Bausch Health Details
2.19.2 Bausch Health Major Business
2.19.3 Bausch Health Parkinson Disease Drug Product and Solutions
2.19.4 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Bausch Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Parkinson Disease Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Parkinson Disease Drug by Company Revenue
3.2.2 Top 3 Parkinson Disease Drug Players Market Share in 2022
3.2.3 Top 6 Parkinson Disease Drug Players Market Share in 2022
3.3 Parkinson Disease Drug Market: Overall Company Footprint Analysis
3.3.1 Parkinson Disease Drug Market: Region Footprint
3.3.2 Parkinson Disease Drug Market: Company Product Type Footprint
3.3.3 Parkinson Disease Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Parkinson Disease Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Parkinson Disease Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Parkinson Disease Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Parkinson Disease Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America Parkinson Disease Drug Consumption Value by Type (2018-2029)
6.2 North America Parkinson Disease Drug Consumption Value by Application (2018-2029)
6.3 North America Parkinson Disease Drug Market Size by Country
6.3.1 North America Parkinson Disease Drug Consumption Value by Country (2018-2029)
6.3.2 United States Parkinson Disease Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Parkinson Disease Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Parkinson Disease Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Parkinson Disease Drug Consumption Value by Type (2018-2029)
7.2 Europe Parkinson Disease Drug Consumption Value by Application (2018-2029)
7.3 Europe Parkinson Disease Drug Market Size by Country
7.3.1 Europe Parkinson Disease Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Parkinson Disease Drug Market Size and Forecast (2018-2029)
7.3.3 France Parkinson Disease Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Parkinson Disease Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Parkinson Disease Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Parkinson Disease Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.3.1 Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2018-2029)
8.3.2 China Parkinson Disease Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Parkinson Disease Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Parkinson Disease Drug Market Size and Forecast (2018-2029)
8.3.5 India Parkinson Disease Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Parkinson Disease Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Parkinson Disease Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America Parkinson Disease Drug Consumption Value by Type (2018-2029)
9.2 South America Parkinson Disease Drug Consumption Value by Application (2018-2029)
9.3 South America Parkinson Disease Drug Market Size by Country
9.3.1 South America Parkinson Disease Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Parkinson Disease Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Parkinson Disease Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.3.1 Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Parkinson Disease Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Parkinson Disease Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Parkinson Disease Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Parkinson Disease Drug Market Drivers
11.2 Parkinson Disease Drug Market Restraints
11.3 Parkinson Disease Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Parkinson Disease Drug Industry Chain
12.2 Parkinson Disease Drug Upstream Analysis
12.3 Parkinson Disease Drug Midstream Analysis
12.4 Parkinson Disease Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Parkinson Disease Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Parkinson Disease Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Parkinson Disease Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Merck Company Information, Head Office, and Major Competitors
Table 6. Merck Major Business
Table 7. Merck Parkinson Disease Drug Product and Solutions
Table 8. Merck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Merck Recent Developments and Future Plans
Table 10. Akorn Company Information, Head Office, and Major Competitors
Table 11. Akorn Major Business
Table 12. Akorn Parkinson Disease Drug Product and Solutions
Table 13. Akorn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Akorn Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Parkinson Disease Drug Product and Solutions
Table 18. GSK Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GSK Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Parkinson Disease Drug Product and Solutions
Table 23. Novartis Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Novartis Recent Developments and Future Plans
Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim Major Business
Table 27. Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
Table 28. Boehringer Ingelheim Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boehringer Ingelheim Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Major Business
Table 32. Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
Table 33. Teva Pharmaceutical Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Teva Pharmaceutical Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Parkinson Disease Drug Product and Solutions
Table 38. Abbvie Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Kyowa Hakko Kirin Pharma Company Information, Head Office, and Major Competitors
Table 41. Kyowa Hakko Kirin Pharma Major Business
Table 42. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
Table 43. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
Table 45. Astellas Pharma Company Information, Head Office, and Major Competitors
Table 46. Astellas Pharma Major Business
Table 47. Astellas Pharma Parkinson Disease Drug Product and Solutions
Table 48. Astellas Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Astellas Pharma Recent Developments and Future Plans
Table 50. Desitin Arzneimittel Company Information, Head Office, and Major Competitors
Table 51. Desitin Arzneimittel Major Business
Table 52. Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
Table 53. Desitin Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Desitin Arzneimittel Recent Developments and Future Plans
Table 55. Endo Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 56. Endo Pharmaceuticals Major Business
Table 57. Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
Table 58. Endo Pharmaceuticals Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Endo Pharmaceuticals Recent Developments and Future Plans
Table 60. F.Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 61. F.Hoffmann-La Roche Major Business
Table 62. F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
Table 63. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. F.Hoffmann-La Roche Recent Developments and Future Plans
Table 65. H.Lundbeck Company Information, Head Office, and Major Competitors
Table 66. H.Lundbeck Major Business
Table 67. H.Lundbeck Parkinson Disease Drug Product and Solutions
Table 68. H.Lundbeck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. H.Lundbeck Recent Developments and Future Plans
Table 70. Valeant Company Information, Head Office, and Major Competitors
Table 71. Valeant Major Business
Table 72. Valeant Parkinson Disease Drug Product and Solutions
Table 73. Valeant Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Valeant Recent Developments and Future Plans
Table 75. Apokyn Company Information, Head Office, and Major Competitors
Table 76. Apokyn Major Business
Table 77. Apokyn Parkinson Disease Drug Product and Solutions
Table 78. Apokyn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Apokyn Recent Developments and Future Plans
Table 80. Orion Company Information, Head Office, and Major Competitors
Table 81. Orion Major Business
Table 82. Orion Parkinson Disease Drug Product and Solutions
Table 83. Orion Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Orion Recent Developments and Future Plans
Table 85. Stada Arzneimittel Company Information, Head Office, and Major Competitors
Table 86. Stada Arzneimittel Major Business
Table 87. Stada Arzneimittel Parkinson Disease Drug Product and Solutions
Table 88. Stada Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Stada Arzneimittel Recent Developments and Future Plans
Table 90. US WorldMeds Company Information, Head Office, and Major Competitors
Table 91. US WorldMeds Major Business
Table 92. US WorldMeds Parkinson Disease Drug Product and Solutions
Table 93. US WorldMeds Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. US WorldMeds Recent Developments and Future Plans
Table 95. Bausch Health Company Information, Head Office, and Major Competitors
Table 96. Bausch Health Major Business
Table 97. Bausch Health Parkinson Disease Drug Product and Solutions
Table 98. Bausch Health Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Bausch Health Recent Developments and Future Plans
Table 100. Global Parkinson Disease Drug Revenue (USD Million) by Players (2018-2023)
Table 101. Global Parkinson Disease Drug Revenue Share by Players (2018-2023)
Table 102. Breakdown of Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Parkinson Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Parkinson Disease Drug Players
Table 105. Parkinson Disease Drug Market: Company Product Type Footprint
Table 106. Parkinson Disease Drug Market: Company Product Application Footprint
Table 107. Parkinson Disease Drug New Market Entrants and Barriers to Market Entry
Table 108. Parkinson Disease Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Parkinson Disease Drug Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Parkinson Disease Drug Consumption Value Share by Type (2018-2023)
Table 111. Global Parkinson Disease Drug Consumption Value Forecast by Type (2024-2029)
Table 112. Global Parkinson Disease Drug Consumption Value by Application (2018-2023)
Table 113. Global Parkinson Disease Drug Consumption Value Forecast by Application (2024-2029)
Table 114. North America Parkinson Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Parkinson Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Parkinson Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Parkinson Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Parkinson Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Parkinson Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Parkinson Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Parkinson Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Parkinson Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Parkinson Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Parkinson Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Parkinson Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Parkinson Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Parkinson Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Parkinson Disease Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Parkinson Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Parkinson Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Parkinson Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Parkinson Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Parkinson Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Parkinson Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Parkinson Disease Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Parkinson Disease Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Parkinson Disease Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Parkinson Disease Drug Raw Material
Table 145. Key Suppliers of Parkinson Disease Drug Raw Materials
List of Figures
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Parkinson Disease Drug Consumption Value Market Share by Type in 2022
Figure 4. Sinemet-CR
Figure 5. Trastal
Figure 6. Madopar
Figure 7. COMT Inhibitor
Figure 8. Other
Figure 9. Global Parkinson Disease Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Parkinson Disease Drug Consumption Value Market Share by Application in 2022
Figure 11. Under 40 Years Old Picture
Figure 12. 40-65 Years Old Picture
Figure 13. Above 65 Years Old Picture
Figure 14. Global Parkinson Disease Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Parkinson Disease Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Parkinson Disease Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Parkinson Disease Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Parkinson Disease Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Parkinson Disease Drug Revenue Share by Players in 2022
Figure 25. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Parkinson Disease Drug Market Share in 2022
Figure 27. Global Top 6 Players Parkinson Disease Drug Market Share in 2022
Figure 28. Global Parkinson Disease Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Parkinson Disease Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Parkinson Disease Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Parkinson Disease Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Parkinson Disease Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Parkinson Disease Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Parkinson Disease Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Parkinson Disease Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Parkinson Disease Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Parkinson Disease Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Parkinson Disease Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Parkinson Disease Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Parkinson Disease Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Parkinson Disease Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Parkinson Disease Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Parkinson Disease Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Parkinson Disease Drug Market Drivers
Figure 67. Parkinson Disease Drug Market Restraints
Figure 68. Parkinson Disease Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Parkinson Disease Drug in 2022
Figure 71. Manufacturing Process Analysis of Parkinson Disease Drug
Figure 72. Parkinson Disease Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
